Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 906

1.

The Chromatin Environment Around Interneuron Genes in Oligodendrocyte Precursor Cells and Their Potential for Interneuron Reprograming.

Boshans LL, Factor DC, Singh V, Liu J, Zhao C, Mandoiu I, Lu QR, Casaccia P, Tesar PJ, Nishiyama A.

Front Neurosci. 2019 Aug 8;13:829. doi: 10.3389/fnins.2019.00829. eCollection 2019.

2.

Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance.

Kita K, Fukuda K, Takahashi H, Tanimoto A, Nishiyama A, Arai S, Takeuchi S, Yamashita K, Ohtsubo K, Otani S, Yanagimura N, Suzuki C, Ikeda H, Tamura M, Matsumoto I, Yano S.

Cancer Sci. 2019 Aug 20. doi: 10.1111/cas.14171. [Epub ahead of print]

3.

The p21 dependent G2 arrest of the cell cycle in epithelial tubular cells links to the early stage of renal fibrosis.

Koyano T, Namba M, Kobayashi T, Nakakuni K, Nakano D, Fukushima M, Nishiyama A, Matsuyama M.

Sci Rep. 2019 Aug 19;9(1):12059. doi: 10.1038/s41598-019-48557-8.

4.

The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan.

Kitano T, Nishikawa H, Suzuki R, Onaka M, Nishiyama A, Kitagawa D, Oka M, Masuo K, Yoshida S.

J Infect Chemother. 2019 Aug 2. pii: S1341-321X(19)30218-1. doi: 10.1016/j.jiac.2019.07.014. [Epub ahead of print]

PMID:
31383498
5.

Podocyte Injury Augments Intrarenal Angiotensin II Generation and Sodium Retention in a Megalin-Dependent Manner.

Koizumi M, Ueda K, Niimura F, Nishiyama A, Yanagita M, Saito A, Pastan I, Fujita T, Fukagawa M, Matsusaka T.

Hypertension. 2019 Sep;74(3):509-517. doi: 10.1161/HYPERTENSIONAHA.118.12352. Epub 2019 Jul 29.

PMID:
31352823
6.

Evaluation of tissue oxygen saturation of the masseter muscle during standardised teeth clenching.

Satokawa C, Nishiyama A, Suzuki K, Uesugi S, Kokai S, Ono T.

J Oral Rehabil. 2019 Jul 22. doi: 10.1111/joor.12863. [Epub ahead of print]

PMID:
31332831
7.

A mouse model of renal fibrosis to overcome the technical variability in ischaemia/reperfusion injury among operators.

Guan Y, Nakano D, Zhang Y, Li L, Tian Y, Nishiyama A.

Sci Rep. 2019 Jul 18;9(1):10435. doi: 10.1038/s41598-019-46994-z.

8.

(Pro)renin receptor accelerates development of sarcopenia via activation of Wnt/YAP signaling axis.

Yoshida N, Endo J, Kinouchi K, Kitakata H, Moriyama H, Kataoka M, Yamamoto T, Shirakawa K, Morimoto S, Nishiyama A, Hashiguchi A, Higuchi I, Fukuda K, Ichihara A, Sano M.

Aging Cell. 2019 Oct;18(5):e12991. doi: 10.1111/acel.12991. Epub 2019 Jul 8.

9.

Clinical Characteristics Associated With Lenvatinib-induced Fistula and Tumor-related Bleeding in Patients With Thyroid Cancer.

Staub Y, Nishiyama A, Suga Y, Fujita M, Matsushita R, Yano S.

Anticancer Res. 2019 Jul;39(7):3871-3878. doi: 10.21873/anticanres.13537.

PMID:
31262915
10.

Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.

Akiyama T, Suzuki N, Ishikawa M, Fujimori K, Sone T, Kawada J, Funayama R, Fujishima F, Mitsuzawa S, Ikeda K, Ono H, Shijo T, Osana S, Shirota M, Nakagawa T, Kitajima Y, Nishiyama A, Izumi R, Morimoto S, Okada Y, Kamei T, Nishida M, Nogami M, Kaneda S, Ikeuchi Y, Mitsuhashi H, Nakayama K, Fujii T, Warita H, Okano H, Aoki M.

EBioMedicine. 2019 Jul;45:362-378. doi: 10.1016/j.ebiom.2019.06.013. Epub 2019 Jun 29.

11.

Comment on "Nutritional situation of enterally fed patients in neurological early rehabilitation and impact of nutritional status on functional outcome".

Imura S, Nishiyama A, Wakabayashi H.

Clin Nutr. 2019 May 29. pii: S0261-5614(19)30250-X. doi: 10.1016/j.clnu.2019.05.025. [Epub ahead of print] No abstract available.

PMID:
31213329
12.

The Durability of Atrial Fibrillation Ablation Using an Oesophageal Temperature Cut-Off of 38°C.

Kimura T, Nishiyama N, Negishi M, Nishiyama A, Takazawa T, Fujisawa T, Nakajima K, Kashimura S, Kunitomi A, Katsumata Y, Nishiyama T, Aizawa Y, Fukuda K, Takatsuki S.

Heart Lung Circ. 2019 Jul;28(7):1050-1058. doi: 10.1016/j.hlc.2018.05.197. Epub 2018 Jun 14.

PMID:
31178023
13.

p.N345K mutation in TARDBP in a patient with familial amyotrophic lateral sclerosis: An autopsy case.

Takeda T, Iijima M, Shimizu Y, Yoshizawa H, Miyashiro M, Onizuka H, Yamamoto T, Nishiyama A, Suzuki N, Aoki M, Shibata N, Kitagawa K.

Neuropathology. 2019 Aug;39(4):286-293. doi: 10.1111/neup.12559. Epub 2019 May 24.

PMID:
31124595
14.

Energy Intake at Admission for Improving Activities of Daily Living and Nutritional Status among Convalescent Stroke Patients.

Nishiyama A, Wakabayashi H, Nishioka S, Nagano A, Momosaki R.

Neurol Med Chir (Tokyo). 2019 Aug 15;59(8):313-320. doi: 10.2176/nmc.oa.2019-0002. Epub 2019 May 22.

15.

The effects of a participatory structured group educational program on the development of CKD: a population-based study.

Sofue T, Okano Y, Matsushita N, Moritoki M, Nishijima Y, Fujioka H, Yamasaki Y, Yamanaka M, Nishiyama A, Minamino T; Kagawa Association of Chronic Kidney Disease Initiatives.

Clin Exp Nephrol. 2019 Aug;23(8):1031-1038. doi: 10.1007/s10157-019-01738-1. Epub 2019 Apr 27.

PMID:
31030309
16.

JSH Statement: Asahikawa declaration in promotion of diversity by the Japanese society of hypertension-the JSH Asahikawa declaration.

Nakamura S, Hasebe N, Yatabe M, Kishi T, Ishida M, Ichihara A, Node K, Ishimitsu T, Itoh H, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nishiyama A, Higaki J, Miura K, Rakugi H, Kawano Y, Tamura K, Yatabe T, Ohya Y, Ito S.

Hypertens Res. 2019 Apr 8. doi: 10.1038/s41440-019-0261-3. [Epub ahead of print] No abstract available.

PMID:
30962519
17.

Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice.

Wang R, Yamada T, Arai S, Fukuda K, Taniguchi H, Tanimoto A, Nishiyama A, Takeuchi S, Yamashita K, Ohtsubo K, Matsui J, Onoda N, Hirata E, Taira S, Yano S.

Mol Cancer Ther. 2019 May;18(5):947-956. doi: 10.1158/1535-7163.MCT-18-0695. Epub 2019 Mar 29.

PMID:
30926637
18.

PET imaging of 11C-labeled coenzyme Q10: Comparison of biodistribution between [11C]ubiquinol-10 and [11C]ubiquinone-10.

Watanabe K, Nozaki S, Goto M, Kaneko KI, Hayashinaka E, Irie S, Nishiyama A, Kasai K, Fujii K, Wada Y, Mizuno K, Mizuseki K, Doi H, Watanabe Y.

Biochem Biophys Res Commun. 2019 May 7;512(3):611-615. doi: 10.1016/j.bbrc.2019.03.073. Epub 2019 Mar 23.

PMID:
30914201
19.

Comparison of the postoperative analgesic efficacies of intravenous acetaminophen and fascia iliaca compartment block inhip fracture surgery: A randomised controlled trial.

Yamamoto N, Sakura S, Noda T, Nishiyama A, Dan'ura T, Matsui Y, Ozaki T.

Injury. 2019 Mar 16. pii: S0020-1383(19)30105-6. doi: 10.1016/j.injury.2019.03.008. [Epub ahead of print]

PMID:
30904248
20.

Neuronal activity in vivo enhances functional myelin repair.

Ortiz FC, Habermacher C, Graciarena M, Houry PY, Nishiyama A, Nait Oumesmar B, Angulo MC.

JCI Insight. 2019 Mar 21;5. pii: 123434. doi: 10.1172/jci.insight.123434.

21.

Parametric standing wave generation of a shallow reflection plane in a nonrigid sample for use in a noninvasive blood glucose monitor.

Kitazaki T, Kawashima N, Yamamoto N, Nomura H, Kang H, Nishiyama A, Wada K, Ishimaru I.

J Biomed Opt. 2019 Mar;24(3):1-7. doi: 10.1117/1.JBO.24.3.036003.

22.

BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses.

Dey A, Yang W, Gegonne A, Nishiyama A, Pan R, Yagi R, Grinberg A, Finkelman FD, Pfeifer K, Zhu J, Singer D, Zhu J, Ozato K.

EMBO J. 2019 Apr 1;38(7). pii: e100293. doi: 10.15252/embj.2018100293. Epub 2019 Mar 6.

23.

Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice.

Kurotaki D, Kawase W, Sasaki H, Nakabayashi J, Nishiyama A, Morse HC 3rd, Ozato K, Suzuki Y, Tamura T.

Blood. 2019 Apr 25;133(17):1803-1813. doi: 10.1182/blood-2018-06-857789. Epub 2019 Feb 22.

PMID:
30796024
24.

Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status.

Fukuda K, Takeuchi S, Arai S, Katayama R, Nanjo S, Tanimoto A, Nishiyama A, Nakagawa T, Taniguchi H, Suzuki T, Yamada T, Nishihara H, Ninomiya H, Ishikawa Y, Baba S, Takeuchi K, Horiike A, Yanagitani N, Nishio M, Yano S.

Cancer Res. 2019 Apr 1;79(7):1658-1670. doi: 10.1158/0008-5472.CAN-18-2052. Epub 2019 Feb 8.

PMID:
30737231
25.

Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System.

Ansary TM, Nakano D, Nishiyama A.

Int J Mol Sci. 2019 Feb 1;20(3). pii: E629. doi: 10.3390/ijms20030629. Review.

26.

Effect of a novel nonsteroidal selective mineralocorticoid receptor antagonist, esaxerenone (CS-3150), on blood pressure and renal injury in high salt-treated type 2 diabetic mice.

Bhuiyan AS, Rafiq K, Kobara H, Masaki T, Nakano D, Nishiyama A.

Hypertens Res. 2019 Jun;42(6):892-902. doi: 10.1038/s41440-019-0211-0. Epub 2019 Jan 21.

PMID:
30664703
27.

Sequential Contribution of Parenchymal and Neural Stem Cell-Derived Oligodendrocyte Precursor Cells toward Remyelination.

Serwanski DR, Rasmussen AL, Brunquell CB, Perkins SS, Nishiyama A.

Neuroglia. 2018 Sep;1(1):91-105. doi: 10.3390/neuroglia1010008. Epub 2018 Jun 12.

28.

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.

Taniguchi H, Yamada T, Wang R, Tanimura K, Adachi Y, Nishiyama A, Tanimoto A, Takeuchi S, Araujo LH, Boroni M, Yoshimura A, Shiotsu S, Matsumoto I, Watanabe S, Kikuchi T, Miura S, Tanaka H, Kitazaki T, Yamaguchi H, Mukae H, Uchino J, Uehara H, Takayama K, Yano S.

Nat Commun. 2019 Jan 16;10(1):259. doi: 10.1038/s41467-018-08074-0.

29.

JSH Statement: Kyoto declaration on hypertension research in Asia.

Ito M, Ishimitsu T, Ichihara A, Itoh H, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Node K, Hasebe N, Higaki J, Miura K, Rakugi H, Tamura K, Kawano Y, Yatabe T, Ohya Y, Ito S.

Hypertens Res. 2019 Jun;42(6):759-760. doi: 10.1038/s41440-018-0172-8. Epub 2019 Jan 7. No abstract available.

PMID:
30617311
30.

Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats.

Li L, Guan Y, Kobori H, Morishita A, Kobara H, Masaki T, Nakano D, Nishiyama A.

Hypertens Res. 2019 Jun;42(6):769-778. doi: 10.1038/s41440-018-0187-1. Epub 2018 Dec 26.

PMID:
30587856
31.

Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer.

Kitagawa C, Iwasaku M, Kogure Y, Ando M, Yoshioka H, Nishiyama A, Watanabe N, Kunimasa K, Tsubouchi K, Oka S, Saka H.

In Vivo. 2019 Jan-Feb;33(1):163-166. doi: 10.21873/invivo.11453.

32.

Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular disease.

Takahashi K, Ueda S, Kobayashi T, Nishiyama A, Fujisawa Y, Sugaya T, Shiota S, Takahashi K, Gohda T, Horikoshi S, Suzuki Y.

Sci Rep. 2018 Dec 18;8(1):17926. doi: 10.1038/s41598-018-36159-9.

33.

Synthesis of 11 C-labeled ubiquinone and ubiquinol via Pd0 -mediated rapid C-[11 C]methylation using [11 C]methyl iodide and 39-demethyl-39-(pinacolboryl)ubiquinone.

Goto M, Nishiyama A, Yamaguchi T, Watanabe K, Fujii K, Watanabe Y, Doi H.

J Labelled Comp Radiopharm. 2019 Feb;62(2):86-94. doi: 10.1002/jlcr.3700. Epub 2019 Jan 8.

34.

(Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations.

Wang J, Shibayama Y, Zhang A, Ohsaki H, Asano E, Suzuki Y, Kushida Y, Kobara H, Masaki T, Wang Z, Nishiyama A.

Br J Cancer. 2019 Jan;120(2):229-237. doi: 10.1038/s41416-018-0350-0. Epub 2018 Dec 17.

PMID:
30555158
35.

Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease.

Nishiyama A.

Hypertens Res. 2019 Mar;42(3):293-300. doi: 10.1038/s41440-018-0158-6. Epub 2018 Dec 6. Review.

PMID:
30523293
36.

Characterization of Heterotrimeric G Protein γ4 Subunit in Rice.

Matsuta S, Nishiyama A, Chaya G, Itoh T, Miura K, Iwasaki Y.

Int J Mol Sci. 2018 Nov 14;19(11). pii: E3596. doi: 10.3390/ijms19113596.

37.

Identification of Heterotrimeric G Protein γ3 Subunit in Rice Plasma Membrane.

Nishiyama A, Matsuta S, Chaya G, Itoh T, Miura K, Iwasaki Y.

Int J Mol Sci. 2018 Nov 14;19(11). pii: E3591. doi: 10.3390/ijms19113591.

38.

Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis.

Ohara Y, Ozeki Y, Tateishi Y, Mashima T, Arisaka F, Tsunaka Y, Fujiwara Y, Nishiyama A, Yoshida Y, Kitadokoro K, Kobayashi H, Kaneko Y, Nakagawa I, Maekura R, Yamamoto S, Katahira M, Matsumoto S.

PLoS One. 2018 Oct 25;13(10):e0204160. doi: 10.1371/journal.pone.0204160. eCollection 2018.

39.

Klotho Ameliorates Medullary Fibrosis and Pressure Natriuresis in Hypertensive Rat Kidneys.

Takenaka T, Inoue T, Miyazaki T, Kobori H, Nishiyama A, Ishii N, Hayashi M, Suzuki H.

Hypertension. 2018 Nov;72(5):1151-1159. doi: 10.1161/HYPERTENSIONAHA.118.11176.

40.

Nrf2-related gene expression is impaired during a glucose challenge in type II diabetic rat hearts.

Thorwald MA, Godoy-Lugo JA, Rodriguez GJ, Rodriguez MA, Jamal M, Kinoshita H, Nakano D, Nishiyama A, Forman HJ, Ortiz RM.

Free Radic Biol Med. 2019 Jan;130:306-317. doi: 10.1016/j.freeradbiomed.2018.10.405. Epub 2018 Oct 11.

PMID:
30316779
41.

The Japanese Society of Hypertension-Digest of plan for the future.

Node K, Kishi T, Tanaka A, Itoh H, Rakugi H, Ohya Y, Miura K, Okamura T, Ishimitsu T, Ichihara A, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Hasebe N, Higaki J, Tamura K, Kawano Y, Yatabe T, Ito S; JSH Future Plan Working Group and Executive Board Members.

Hypertens Res. 2018 Dec;41(12):989-990. doi: 10.1038/s41440-018-0111-8. Epub 2018 Oct 11. No abstract available.

PMID:
30310169
42.

NG2 expression in NG2 glia is regulated by binding of SoxE and bHLH transcription factors to a Cspg4 intronic enhancer.

Gotoh H, Wood WM, Patel KD, Factor DC, Boshans LL, Nomura T, Tesar PJ, Ono K, Nishiyama A.

Glia. 2018 Dec;66(12):2684-2699. doi: 10.1002/glia.23521. Epub 2018 Oct 10.

PMID:
30306660
43.

Involvement of complement 3 in the salt-sensitive hypertension by activation of renal renin-angiotensin system in spontaneously hypertensive rats.

Negishi E, Fukuda N, Otsuki T, Katakawa M, Komatsu K, Chen L, Tanaka S, Kobayashi H, Hatanaka Y, Ueno T, Endo M, Mashimo T, Nishiyama A, Abe M.

Am J Physiol Renal Physiol. 2018 Dec 1;315(6):F1747-F1758. doi: 10.1152/ajprenal.00370.2018. Epub 2018 Sep 26.

PMID:
30256128
44.

Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type 2 diabetes.

Takenaka T, Kobori H, Miyazaki T, Suzuki H, Nishiyama A, Ishii N, Yamashita M, Hayashi M.

Acta Physiol (Oxf). 2019 Feb;225(2):e13190. doi: 10.1111/apha.13190. Epub 2018 Oct 16.

45.

A novel role of renin inhibitor in the complement cascade.

Nakano D, Nishiyama A.

Kidney Int. 2018 Oct;94(4):650-652. doi: 10.1016/j.kint.2018.05.025.

PMID:
30243307
46.

Effects of the selective chymase inhibitor TEI-F00806 on the intrarenal renin-angiotensin system in salt-treated angiotensin I-infused hypertensive mice.

Ansary TM, Urushihara M, Fujisawa Y, Nagata S, Urata H, Nakano D, Hirofumi H, Kitamura K, Kagami S, Nishiyama A.

Exp Physiol. 2018 Nov;103(11):1524-1531. doi: 10.1113/EP087209. Epub 2018 Sep 14.

PMID:
30137655
47.

The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Sympathetic Nervous Activity.

Wan N, Rahman A, Hitomi H, Nishiyama A.

Front Endocrinol (Lausanne). 2018 Jul 26;9:421. doi: 10.3389/fendo.2018.00421. eCollection 2018.

48.

Targeting ability of self-assembled nanomedicines in rat acute limb ischemia model is affected by size.

Suhara M, Miura Y, Cabral H, Akagi D, Anraku Y, Kishimura A, Sano M, Miyazaki T, Nakamura N, Nishiyama A, Kataoka K, Koyama H, Hoshina K.

J Control Release. 2018 Sep 28;286:394-401. doi: 10.1016/j.jconrel.2018.07.049. Epub 2018 Aug 1.

49.

A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice.

Zhang Y, Nakano D, Guan Y, Hitomi H, Uemura A, Masaki T, Kobara H, Sugaya T, Nishiyama A.

Kidney Int. 2018 Sep;94(3):524-535. doi: 10.1016/j.kint.2018.05.002. Epub 2018 Jul 23.

PMID:
30045814
50.

Organotypic Slice Cultures to Study Oligodendrocyte Proliferation, Fate, and Myelination.

Sherafat A, Hill RA, Nishiyama A.

Methods Mol Biol. 2018;1791:145-156. doi: 10.1007/978-1-4939-7862-5_11.

Supplemental Content

Loading ...
Support Center